Overview
| SQSTM1/p62 Protein | |
|---|---|
| Symbol | SQSTM1 |
| Full Name | SQSTM1/p62 |
| Type | Protein |
| UniProt | Search UniProt |
| Associated Diseases | AD, ADH, ALI, ALS, ALZHEIMER |
| KG Connections | 2520 edges |
SQSTM1 (sequestosome-1), commonly called p62, is a multifunctional scaffold protein that couples ubiquitin tagging, autophagosome recruitment, and stress-response signaling.1p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagyOpen reference2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference In neurodegeneration biology, p62 is best interpreted as a flux integrator: it accumulates when degradative systems fail, but it is also required for selective cargo capture and clearance when those systems work.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference This dual role explains why p62 can appear protective in early stress adaptation yet still mark disease progression in advanced proteinopathy.
In neurons and glia, p62 participates in proteostasis triage across protein aggregation, oxidative stress, and inflammatory signaling axes.4Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference5p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcriptionOpen reference Mechanistically, it intersects with pathways central to amyotrophic lateral sclerosis (ALS), frontotemporal degeneration (FTD), tauopathies, and related disorders where autophagy-lysosome throughput is rate-limiting.6Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic OpportunitiesOpen reference7Altered proteostasis in aging and neurodegenerative diseaseOpen reference
Domain Architecture And Functional Consequences
SQSTM1 is a modular protein with architecture that enables simultaneous signaling and cargo trafficking.
PB1 Domain: Oligomerization And Signal Platform
The N-terminal PB1 domain mediates p62 self-assembly and higher-order complex formation. Oligomerization supports cargo clustering and concentrates autophagy machinery around ubiquitinated substrates.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference
LIR Motif: LC3/GABARAP Coupling
The LC3-interacting region (LIR) directly binds Atg8-family proteins, functionally docking p62-cargo complexes to autophagosomal membranes.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference0 This step is required for efficient selective autophagy of ubiquitinated inclusions.
UBA Domain: Ubiquitin Chain Recognition
The C-terminal UBA domain binds polyubiquitin chains and enables cargo selection. Disease-associated changes in p62 function can impair this recognition-to-delivery step and produce apparent “cargo capture without clearance” states.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference12p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference2
KIR Region: KEAP1-NRF2 Redox Interface
A KEAP1-interacting region allows p62 to modulate NRF2 signaling. Under stress, p62 can sequester KEAP1 and enhance antioxidant transcription programs, creating feedback between proteostasis demand and redox defense.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference32p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference4
Core Mechanisms Relevant To Neurodegeneration
1. Selective Autophagy Of Ubiquitinated Cargo
p62 is a canonical selective autophagy receptor: it links ubiquitinated proteins to autophagosomes via LC3 binding.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference5 Experimental disruption of p62 pathways increases aggregate burden and destabilizes cellular quality control.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference6
2. Flux Sensing Versus Cargo Throughput
Static p62 abundance is not equivalent to increased autophagic activity. High p62 may indicate active adaptation or blocked degradation, depending on lysosomal throughput and LC3 flux context.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference72p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference8 For translational studies, p62 should therefore be interpreted with orthogonal flux measurements, not as a standalone endpoint.
3. Ubiquitylation/Phosphoregulation Of Receptor Activity
p62 function is dynamically tuned by post-translational modifications. Ubiquitylation can increase receptor activity for selective autophagy under ubiquitin stress, and phosphorylation-dependent regulation influences redox-signaling crosstalk and condensate behavior under stress.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference92p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference02p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference1
4. Proteostasis-Inflammation Coupling
By integrating stress-signaling inputs with degradative handling, p62 sits at a proteostasis-inflammation interface. In neurodegeneration, this coupling likely contributes to self-reinforcing loops between protein accumulation and tissue injury.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference22p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference3
Human Genetics And Disease Associations
ALS/FTD Spectrum
SQSTM1 variants have been reported in patients with FTD and FTD-ALS phenotypes.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference42p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference5 Functional follow-up studies support a mechanism where mutation-linked p62 dysregulation impairs selective autophagy and anti-oxidative stress buffering.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference6
From an evidence-quality perspective, SQSTM1 is a contributory risk/modifier axis in many cohorts rather than a single dominant driver in most sporadic disease. That distinction matters for trial design: pathway-stratified enrollment and mechanism-proximal endpoints are more defensible than broad unselected populations.
Interaction With TBK1-Centered Autophagy Networks
ALS-linked TBK1 perturbations can reduce p62 phosphorylation dynamics and alter downstream autophagic handling, including effects on pathogenic protein clearance pathways.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference7 This places SQSTM1 within a broader autophagy receptor-kinase network where upstream defects can phenocopy direct receptor dysfunction.
Tauopathy Context
Although SQSTM1 mutations are not primary monogenic causes of classic 4R-tau syndromes, p62 pathway behavior remains biologically relevant because tau aggregation and lysosomal insufficiency converge on selective-autophagy reserve.2p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference82p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 bindingOpen reference9 In this framework, p62 serves as a mechanistic bridge between aggregate burden and degradative capacity.
Translational And Biomarker Implications
Interpreting p62 In Preclinical And Clinical Studies
p62 should be modeled as a state variable, not a binary marker. Interpretation is strongest when combined with:
-
LC3-II dynamics and validated flux assays.3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference03Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference1
-
Insoluble/soluble cargo partitioning profiles.3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference2
-
Oxidative-stress response markers when KEAP1-NRF2 engagement is expected.3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference33Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference4
-
Disease-context readouts such as TDP-43/tau burden and neuroinflammatory metrics.3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference53Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference6
What A “Good” p62 Shift Looks Like
A therapeutic decrease in p62 can indicate improved clearance, but only if accompanied by evidence of restored substrate turnover. A decrease without cargo movement can also reflect reduced receptor competence. Conversely, a transient increase may occur during effective mobilization of stressed proteomes.
Patient-Selection Logic
Programs targeting p62-adjacent pathways are likely most actionable in cohorts with documented autophagy-lysosome stress signatures, ALS/FTD-related proteostasis phenotypes, or molecular evidence of receptor-kinase network disruption.3Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference73Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference83Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient miceOpen reference9
Therapeutic Strategy Framing
Strategy A: Improve End-To-End Autophagy Throughput
Interventions should prioritize restoration of full cargo-to-lysosome flux, not isolated reduction of p62 signal intensity.4Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference04Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference1
Strategy B: Rebalance Receptor Regulation
Targeting phosphorylation/ubiquitylation control points that tune p62 receptor activity may improve selective cargo handling in genetically sensitized contexts.4Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference24Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference34Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference4
Strategy C: Couple Proteostasis And Redox Modulation
Because p62 couples degradative stress and NRF2 biology, combination approaches that co-manage aggregate load and oxidative stress may have better mechanistic coherence than single-axis programs.4Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference54Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference64Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagyOpen reference7
Evidence Boundaries And Open Questions
-
Which SQSTM1 variant classes map reproducibly to disease-specific phenotypes versus broad proteostasis risk?
-
Which p62 post-translational states are most predictive of treatment response across ALS/FTD versus tau-first syndromes?
-
How should p62-centered biomarkers be harmonized across tissue compartments (CSF, blood, and tissue/pathology endpoints)?
These are tractable questions for prospective translational studies that embed mechanism-proximal biomarker panels and predefined flux interpretation rules.
Pathway & Interaction Diagram
Interactive diagram showing SQSTM1 key relationships in the SciDEX knowledge graph (15 connections shown).
flowchart TD
SQSTM1(["SQSTM1"])
NFE2L2(["NFE2L2"])
A["utophagyAutophagy"]
A["lsAls"]
C["ancerCancer"]
T["umorTumor"]
I["nflammationInflammation"]
M["torMtor"]
MTOR(["MTOR"])
P62(["P62"])
SQSTM1 -->|"activates"| NFE2L2
SQSTM1 -->|"regulates"| Autophagy
SQSTM1 -->|"interacts with"| Autophagy
SQSTM1 -->|"associated with"| Autophagy
SQSTM1 -->|"associated with"| Als
SQSTM1 -->|"regulates"| Cancer
SQSTM1 -->|"activates"| Autophagy
SQSTM1 -->|"activates"| Tumor
SQSTM1 -->|"activates"| Als
SQSTM1 -.->|"inhibits"| Als
SQSTM1 -->|"activates"| Inflammation
SQSTM1 -->|"activates"| Mtor
SQSTM1 -->|"activates"| MTOR
SQSTM1 -->|"associated with"| P62
SQSTM1 -->|"activates"| P62
style SQSTM1 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0See Also
External Links
References
- p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
- p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding
- Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
- Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy
- p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription
- Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
- Altered proteostasis in aging and neurodegenerative disease
- SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis
- Ubiquitylation of p62/sequestosome1 activates its autophagy receptor function and controls selective autophagy upon ubiquitin stress
- Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress
- ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway
- Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration
- ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation
Sister wikis (recently updated · no domain on this page)
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- Agent Recipe: AI-for-Biology Closed-Loop with Reviewer Handoffs and Eval Contracts
- test
- JGBO-I27: Top 10 GBO Questions for Prioritization
- JGBO-I27: Top 10 GBO Questions for Prioritization
- Design Brief: Beta-test Evaluation Protocol for SciDEX v2 Design Trajectories
- Andy — Showcase Findings (auto-curated)
- Kris — Showcase Findings (auto-curated)
Recent activity here
No recent events touching this page.